Juvisync Interactions
There are 570 drugs known to interact with Juvisync (simvastatin/sitagliptin), along with 10 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 62 are major, 497 are moderate, and 11 are minor.
- View all 570 medications that may interact with Juvisync
- View Juvisync alcohol/food interactions (2)
- View Juvisync disease interactions (10)
Most frequently checked interactions
View interaction reports for Juvisync (simvastatin / sitagliptin) and the medicines listed below.
- Accupril (quinapril)
- Accuretic (hydrochlorothiazide / quinapril)
- Aceon (perindopril)
- Acetylsalicylic Acid (aspirin)
- acyclovir
- Advicor (lovastatin / niacin)
- Allegra (fexofenadine)
- Allegra-D 12 Hour (fexofenadine / pseudoephedrine)
- allopurinol
- Altace (ramipril)
- alteplase
- Astelin (azelastine nasal)
- Astepro (azelastine nasal)
- Ativan (lorazepam)
- Atrovent (ipratropium)
- baclofen
- Benadryl (diphenhydramine)
- Capoten (captopril)
- Capozide (captopril / hydrochlorothiazide)
- Cardizem (diltiazem)
- Celexa (citalopram)
- chlorzoxazone
- Clarinex (desloratadine)
- Clarinex-D 12 Hour (desloratadine / pseudoephedrine)
- Claritin (loratadine)
- Claritin-D (loratadine / pseudoephedrine)
- Colace (docusate)
- Coreg (carvedilol)
- doxycycline
- levothyroxine
Juvisync alcohol/food interactions
There are 2 alcohol/food interactions with Juvisync (simvastatin / sitagliptin).
Juvisync disease interactions
There are 10 disease interactions with Juvisync (simvastatin / sitagliptin) which include:
- liver disease
- renal dysfunction
- renal dysfunction
- pancreatitis
- cognitive impairment
- diabetes
- renal disease
- rhabdomyolysis
- heart failure
- liver dysfunction
Report options
More about Juvisync (simvastatin / sitagliptin)
- Juvisync consumer information
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: antidiabetic combinations
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Leqvio
Leqvio is used in adults with primary hyperlipidemia to reduce low-density lipoprotein (LDL-C) ...
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Mounjaro
Mounjaro is used to treat type 2 diabetes in adults. It is a subcutaneous injection that can be ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Repatha
Repatha is used to lower high cholesterol alongside dietary changes and to reduce the risk of major ...
Rosuvastatin
Rosuvastatin is a prescription medication used to treat high cholesterol and prevent heart disease ...
Metformin
Metformin is an oral diabetes medicine used together with diet and exercise to improve blood sugar ...
Atorvastatin
Atorvastatin is a cholesterol-lowering medication that blocks the production of cholesterol. Learn ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
